Figure 3 | Scientific Reports

Figure 3

From: RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model

Figure 3

RGN-259 reduced corneal fluorescein staining comparable to that of LFA. (A) Corneal fluorescein staining was imaged using a slit lamp biomicroscope. (B) Change in the corneal fluorescein staining scores. *P < 0.05 vs. the corresponding value in the baseline desiccation stressed group. #P < 0.05 vs. the value in the vehicle-treated group. §P < 0.05 vs. the value in the RGN-259, 2 times per day group. †P < 0.05 vs. the value in the RGN-259, 4 times per day group. P < 0.05 vs. the value in the CsA group. ‡P < 0.05 vs. the value in the DQS group. &P < 0.05 vs. the value in the LFA group.

Back to article page